Established in 1993, Huadong Medicine Co Ltd specializes in the production and sales of antibiotics, Chinese medicine, synthetic drugs and genetic engineering drugs, as well as a wholesale business supplying Chinese herbal medicines, medical apparatuses and instruments.
Huadong issued 50 million A-shares at the Shenzhen Stock Exchange in December 1999. At present, the registered capital of the company is 14.58 million yuan ($217.14 million). The company and its main subsidiaries employ more than 8,000 people. In 2017, the company realized an operating revenue of 27.83 billion yuan.
The company is a major listed pharmaceutical company in Hangzhou, with businesses in pharmaceutical R&D, manufacturing, distribution, retail and logistics, and undertakes the task of special drug storage for the country.
Huadong is also the largest pharmaceutical commercial enterprise in Zhejiang province, whose business covers a wide range of industries, including pharmaceutical business operation, retail, supply chain management and big health. The company has a complete business mechanism and a thorough terminal market network. It is considered a highly automated medical logistics center in Zhejiang province.
Its major subsidiary, Hangzhou Sino-US Huadong Pharmaceutical Co Ltd, is one of the top 50 pharmaceutical enterprises in China. It is also a national high-tech enterprise and a national intellectual property demonstration enterprise, as well as one of the top 100 technological innovation enterprises in Zhejiang. Sino-US Huadong's annual sales exceeded 6 billion yuan in 2017. The company is leading the way in the research, development and production of organ transplantation and diabetes drugs in China.
Centering on the development of its medical business, the company has always adhered to the core values of "charity, integrity, persistence and pragmatism" and made significant contributions to the cause of public health.
Over the years, the company has been highly recognized by China's mainstream media and market for its sound management and excellent business performance. It has been awarded many honorary titles, including one of the Top 100 on China's main board-listed companies, China's listed companies investor relations selection Tianma award and Top 20 most competitive listed pharmaceutical companies in 2017. In that year it also was selected as one of the Top 50 listed companies by Forbes Asia.
Address: 866 Mogan Mountain Rd, Hangzhou
Copyright©2019 China Daily. All rights reserved.